Skip to main content

A Potential Breakthrough For Hair Loss In Men

Androgenetic Alopecia Clinical Trials Are Now Enrolling!

Male pattern baldness, also referred to as male pattern baldness, is a common occurrence affecting that affects up to 50% of men by the age of 50. It is strongly believed to have a genetic predisposition in 80% of its cases. Having hair loss affects one’s self-esteem and causes much anxiety. This warrants the need to develop a viable treatment option.

Revival Research Institute is carrying out androgenetic alopecia clinical trials in Michigan. With this clinical trial for hair loss aims to study the safety and efficacy of an investigational product that could potentially help with hair loss.

You may be eligible for the androgenetic alopecia clinical trials in Michigan if you are:

  • Males aged 18 years or older
  • Suffering hair loss in the temple region or the top of the head

We are conducting phase 3 clinical trials for hair loss in men. This could be the breakthrough we need to fight against hair loss.

*To participate in the androgenetic alopecia clinical trials, please fill out the form, and someone from our research team will give you a call.
**The study drug and study-related care will be provided at no cost. No insurance is required to participate.

Androgenetic alopecia clinical trials in Michigan

About Androgenetic Alopecia Clinical Trials: Clinical Trials For Hair Loss

Revival Research Institute is conducting a Phase 3 clinical trial that may last up to 14 months. This study will help us learn if the investigational drug is safe and effective to use. The goal of the androgenetic alopecia clinical trials in Michigan is to observe whether the topical application of this drug can help stop hair loss in people and improve their condition.

The investigational therapy may help with hair regrowth, by binding to the receptors that result in hair loss. If you are eligible to participate in the clinical trial and decide to take part, you might receive either the study drug or drug vehicle.

*Participating in the androgenetic alopecia clinical trials in Michigan is completely voluntary. You can discontinue or stop taking part at any time.
*There will be other study requirements the study team will discuss with you if you participate in this study.

Get Started: What to Expect?

If you meet the study criteria for the clinical trials for hair loss in Michigan, you will be randomly assigned to one of two groups. One of the groups will receive the investigational alopecia study drug. The other group will receive the study vehicle. Every participant will have an equal chance of receiving the investigational drug or the vehicle solution. As this is a double-blind research study, neither you nor your study members of the research team will know who gets to receive the study drug.

After you fill out the form above, someone from our research will give you a call. If you fit the androgenetic alopecia clinical trials in Michigan eligibility criteria, you might be invited to the study site’s location (within a 50-mile radius). Before you decide to participate, our study team will brief you on all details about participating in the clinical trial, including the risks and benefits. Throughout the study, the research team will monitor your condition and look out for any adverse or severely adverse effects.

Condition:

Androgenetic Alopecia

Length of Study:

14 months

No. of Study Visits:

Approx. 8 onsite visits

About Androgenetic Alopecia

About Androgenetic alopecia

Alopecia is the medical term for hair loss, while androgenetic alopecia is its type that results from excessive response to androgens (reproductive hormones that are responsible for puberty). Androgenetic alopecia can occur not only in males but in females as well. Hair loss pattern in women differs from men as it results in thinning of hair on the top of the head and widening of the hairline. In men, however, it is much more noticeable with hairline recession and loss of hair from the top of the head. It is often linked to other medical conditions, such as stiffening of the blood vessels, but the most noticeable damage it does is to one’s self-image and confidence which is why Revival Research Institute is carrying out clinical trials for hair loss in Michigan through its androgenetic alopecia clinical trials.

Frequently Asked Questions

What are the 7 stages of male pattern baldness?

Stage 1: Minimum or no hair loss or hairline recession.

Stage 2: Slight hair loss in the temple region which is the skin between your ears and forehead.

Stage 3: Hairline recession around the temples, with a characteristic “M” or “U” shape recession.

Stage 4: The hairline recedes even more and the hair at the top of your head (crown) starts thinning.

Stage 5: The recession at the front connects to the bald spot on the crown.

Stage 6: Hair between your temples and crown is thinning or gone.

Stage 7: There is no hair on the top of your head and only a thin band of hair around the side of the head.

Who can enroll in androgenetic alopecia clinical trials in Michigan?

Healthy males who are above the age of 18 years suffer from hair loss at the temple region and the top of the head. Participants should be willing to maintain the same hairstyle, hair length, hair color, hair care products like shampoo, and habits throughout the clinical trials for hair loss. When you contact the study team, they will let you know of additional participation criteria.

What causes androgenetic alopecia or male pattern baldness?

Male pattern baldness is primarily a result of the male sex hormone, testosterone, being converted to dihydrotestosterone. It causes the hairline to recede and causes thinning of the hair on the scalp.

Will I be compensated for my time and travel in the clinical trials for hair loss?

If you decide to participate in the androgenetic alopecia clinical trials in Michigan, you will receive reimbursement for your time and travel. The study drug and any study-related procedures will be provided at no cost.

What is the difference between a placebo and a vehicle?

A placebo and a vehicle are often confused with one another — but they’re different! A vehicle is a medium that enhances the delivery or efficacy of a drug and is often used in dermatological applications. It contains relatively inert substances while the placebo is designed to have no pharmacological effects.

Close Menu